M. Choong, und G. Tsafnat. BMC medical research methodology, 12 (1):
176(Januar 2012)JID: 100968545; 2012/08/07 received; 2012/11/22 accepted; 2012/11/22 aheadofprint; aheadofprint;.
E. Evangelou, G. Tsianos, und J. Ioannidis. BMJ (Clinical research ed.), 336 (7656):
1287-90(Juni 2008)4633<m:linebreak></m:linebreak>LR: 20081120; JID: 8900488; CIN: BMJ. 2008 Jun 7;336(7656):1258-9. PMID: 18495633; OID: NLM: PMC2413393; 2008/05/21 aheadofprint; ppublish;<m:linebreak></m:linebreak>Mesures de resultats.
R. Goldberg, J. Gore, B. Barton, und J. Gurwitz. The American journal of medicine, 127 (5):
379-84(Mai 2014)Comparacions múltiples; Composite endpoints; Introductori.
L. Thabane, G. Wells, R. Cook, R. Platt, J. Pogue, E. Pullenayegum, D. Matthews, T. McCready, P. Devereaux, J. Cairns und 1 andere Autor(en). Trials, (Januar 2011)6243<m:linebreak></m:linebreak>GR: Canadian Institutes of Health Research/Canada; JID: 101263253; OID: NLM: PMC3049182; 2010/11/14 received; 2011/02/18 accepted; 2011/02/18 aheadofprint; epublish;<m:linebreak></m:linebreak>Recursos/Organització; Consulting.
R. Tuma. Journal of the National Cancer Institute, 101 (21):
1439-41(November 2009)5434<m:linebreak></m:linebreak>JID: 7503089; 0 (Antineoplastic Agents); 2009/10/14 aheadofprint; ppublish;<m:linebreak></m:linebreak>Anàlisi de supervivència.
M. Koller, T. Stijnen, E. Steyerberg, und J. Lubsen. Journal of clinical epidemiology, 61 (4):
365-72(April 2008)4586<m:linebreak></m:linebreak>PUBM: Print-Electronic; JID: 8801383; 2006/05/23 received; 2007/05/08 revised; 2007/05/10 accepted; 2007/10/15 aheadofprint; ppublish;<m:linebreak></m:linebreak>Mesures d'associació.
Y. Wang, L. Meyerson, Y. Tang, und N. Qian. Journal of the neurological sciences, 285 (1-2):
206-11(Oktober 2009)5489<m:linebreak></m:linebreak>JID: 0375403; 0 (Antibodies, Monoclonal); 0 (Immunologic Factors); 0 (natalizumab); 2009/03/05 received; 2009/07/15 revised; 2009/07/22 accepted; 2009/08/25 aheadofprint; ppublish;<m:linebreak></m:linebreak>Anàlisi de dades; Count data.
C. Gerlinger, und T. Schmelter. Pharmaceutical statistics, 10 (5):
410-3(2011)6376<m:linebreak></m:linebreak>MDCI; Tests d'equivalència; Mesures de resultats.
D. Revicki, R. Hays, D. Cella, und J. Sloan. Journal of clinical epidemiology, 61 (2):
102-9(Februar 2008)4488<m:linebreak></m:linebreak>PUBM: Print-Electronic; GR: AG-02-004/AG/United States NIA; GR: AG20679-01/AG/United States NIA; GR: P20-MD00148-01/MD/United States NCMHD; JID: 8801383; RF: 52; 2006/10/06 received; 2007/03/27 revised; 2007/03/31 accepted; 2007/08/03 aheadofprint; ppublish;<m:linebreak></m:linebreak>MDCI.
V. Gebski, I. Marschner, und A. Keech. The Medical journal of Australia, 176 (10):
491-2(Mai 2002)5111<m:linebreak></m:linebreak>LR: 20071115; JID: 0400714; 2002/03/20 received; 2002/04/08 accepted; ppublish;<m:linebreak></m:linebreak>Mesures de resultats.
P. Austin, und A. Laupacis. The international journal of biostatistics, 7 (1):
6(Januar 2011)6729<m:linebreak></m:linebreak>TY: GENERIC; J2: ijb; M1: 1;<m:linebreak></m:linebreak>Mesures de resultats; Observacionals; Propensity score.
S. Heritier, V. Gebski, und A. Keech. The Medical journal of Australia, 179 (8):
438-40(Oktober 2003)3388<m:linebreak></m:linebreak>Intention to treat.